BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

BioArctic Sweden

View original content:https://www.prnewswire.co.uk/news-releases/bioarctic-to-initiate-next-cohorts-in-exidavnemab-phase-2a-study-after-positive-safety-review-302480954.html